Area of research
Analytical Chemistry · Spectroscopy
Research interest
Research interests include Analytical Methods in Pharmaceuticals, Analytical Chemistry and Chromatography, Antibiotics Pharmacokinetics and Efficacy, and Radiopharmaceutical Chemistry and Applications.
Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications
Preclinical evaluation of <sup>225</sup>Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha Therapy.
Hematological toxicity of [<sup>225</sup>Ac]Ac-PSMA-617 and [<sup>177</sup>Lu]Lu-PSMA-617 in RM1-PGLS syngeneic mouse model.
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Correction: Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Evaluating [225Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice
Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Correlation of <sup>68</sup>Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study
STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [<sup>18</sup>F]FLT PET imaging.
<sup>68</sup>Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
Noninvasive PET Imaging of CDK4/6 Activation in Breast Cancer.
Multimodal imaging of bacterial-host interface in mice and piglets with <i>Staphylococcus aureus</i> endocarditis
Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species
Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.
Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.
Noninvasive PET Imaging of CDK4/6 Activation in Breast Cancer
Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis
Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease
Non-invasive PET Imaging of PARP1 Expression in Glioblastoma Models
Dual-Modality Optical/PET Imaging of PARP1 in Glioblastoma